APA (7th ed.) Citation

Li, D., Zhong, Q., Xiao, D., Wang, W., Xie, L., Peng, M., . . . Yang, X. (2025). Novel combination therapy with phenformin enhances the effects of lenvatinib in hepatocellular carcinoma via AMPK-mediated PDGFRβ degradation. Cancer Cell International, 25(1), 1. https://doi.org/10.1186/s12935-025-04012-5

Chicago Style (17th ed.) Citation

Li, Duo, et al. "Novel Combination Therapy with Phenformin Enhances the Effects of Lenvatinib in Hepatocellular Carcinoma via AMPK-mediated PDGFRβ Degradation." Cancer Cell International 25, no. 1 (2025): 1. https://doi.org/10.1186/s12935-025-04012-5.

MLA (9th ed.) Citation

Li, Duo, et al. "Novel Combination Therapy with Phenformin Enhances the Effects of Lenvatinib in Hepatocellular Carcinoma via AMPK-mediated PDGFRβ Degradation." Cancer Cell International, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12935-025-04012-5.